Compound Detail
CHEMBL5437139
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CC1(C)C(=O)N2c3ccccc3[C@@]3(C[C@@H](n4cnc5ccccc5c4=O)C(=O)O3)[C@@H]2N1O
Basic Information
| ChEMBL ID | CHEMBL5437139 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | NRWLZYIHXSJKCU-MONBJTKQSA-N |
0
Targets
1
Activities
1
Assay Types
0
PK Parameters
5
Publications
0
Known Names
Molecular Properties
432.4
MW (Da)
1.94
ALogP
8
HBA
1
HBD
105.0
PSA (Ų)
0.59
QED
0
Ro5 Violations
1
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas.
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 36375335 | 10.1016/j.ejmech.2022.114915 | HepG2 | 1 |
| 36375335 | 10.1016/j.ejmech.2022.114915 | Unchecked | 1 |
| 36375335 | 10.1016/j.ejmech.2022.114915 | A549 | 1 |
| 36375335 | 10.1016/j.ejmech.2022.114915 | MCF7 | 1 |
| 36375335 | 10.1016/j.ejmech.2022.114915 | SK-MEL-28 | 1 |
Data from ChEMBL 36 via Core Engine